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discontinuing rabeprazole for effectiveness or ADE; N =
249 (6%). Estimated annual PPI acquisition costs were
reduced 50%, avoiding over 1/2 million dollars (US) in
pharmacy acquisition costs despite a 32% increase in
units dispense. Final cost analysis will include the effect
of dose-creep in rabeprazole patients and associated clinic
costs. CONCLUSION: Rabeprazole appears safe, effec-
tive, and cost-saving as indicated by the low number 
of patients discontinuing rabeprazole for either clinical
failure or intolerance. Cost savings were signiﬁcant but
offset by a predictable and substantial increase in use.
*Data available 10-months post interchange; 1-year data
will be presented at meeting.
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OBJECTIVES: If multiple diagnostic modalities are avail-
able, an insurmountable number of strategies have to be
compared to determine the most efﬁcient one. Our aim is
to develop a multistage decision analytic model to decide
upon the most cost-effective diagnostic strategy to guide
the treatment of faecal incontinence by physiotherapy and
surgical anal sphincter repair. METHODS: Incremental
cost-effectiveness analysis of diagnostic strategies, each
including one to seven diagnostic modalities, ﬁve of which
consist of two or three subtests. The primary endpoint is
the success of physiotherapy or, in case of failure, the
success of subsequent operative anal sphincter repair. 
An informed choice was made for a restricted set of
strategies eligible for economic evaluation and modelling,
based on methodological papers and on expert opinion
on patient logistics. RESULTS: In theory, 8,41E + 13 
possible decisions have to be evaluated for each therapy.
This number can be reduced to 1,063,859, if the most 
cost-effective subtest combination within each diagnostic
modality is determined beforehand. This is very likely the
most informative combination, for the cost differences are
minimal. Next, four modalities make up an inseparable
diagnostic test array from the patients’ logistics point of
view. Within this array individual tests may be omitted
and the order of tests is redundant. The array further
reduces the number of decisions to be evaluated to 777.
CONCLUSIONS: The number of possible diagnostic
strategies can be succesfully reduced to manageable pro-
portions through an evaluation of subtest combinations
ﬁrst and by taking into account patients’ logistics.
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OBJECTIVE: Compare the Health Related Quality of
Life (HRQoL) and Psychological Well-being (PW) of 
IBS and non-IBS patients (controls) and evaluate the 
perceived stress of IBS patients’ relatives. METHODS:
Observational, prospective study including a sample of
455 IBS patients meeting Rome II criteria, 69 controls,
and 195 IBS patients’ relatives. The controls were selected
from those subjects who had attended a health centre
with a relative due to digestive problems (excluding IBS).
All samples were selected from the consulting rooms of
86 Spanish gastroenterologists and physicians. In order
to measure HRQoL and PW patients and controls 
completed the EQ-5D and Psycological Well-Being 
Index (PGWBI). Patients’ relatives completed an adapted
version of the Levenstein’s Perceived Stress Question-
naire’ (LPSQ). RESULTS: The mean (SD) age of patients
was 43(14) years and 76.5% were female. There were 
no statistical signiﬁcant differences in age and gender
between patients and controls. 67.9% of patients pre-
sented some concomitant disease, while in controls the
percentage was lower (39.1%) (p < 0.01). Patients pre-
sented worse HRQoL than controls, presenting a higher
presence of problems in all EQ-5D dimensions (p < 0.05),
except self-care. 76.5 and 54.7% of patients declared
having pain and anxiety problems, respectively, compared
to 15.9 and 20.3% of controls. In terms of PGWBI,
patients presented more problems than controls in all
dimensions (p < 0.05) except ‘alimentation’ and ‘sexual
relations’. Relatives obtained a mean (SD) LPSQ score 
of 0.54 (0.12) on a scale from 0 to 1 (maximum stress).
Relatives of patients with a higher IBS severity (rated by
patients and doctors) showed a higher stress level than
those relatives of less severe patients. CONCLUSIONS:
Patients with IBS showed a signiﬁcant deterioration in
HRQoL, in almost all HRQoL dimensions, compared
with non-IBS subjects. Relatives showed varying levels of
stress according to the patient’s IBS severity, stress being
higher in relatives of more severe patients.
